The global carrier screening market is anticipated to touch USD 4,200 million at a 15.94% CAGR between 2020- 2030, according to the new report by Market Research Future (MRFR). Carrier screening, simply put, is a genetic test that is used for determining whether a healthy individual is a carrier of any recessive genetic disease. It has wide applications in clinics, physician offices, reference laboratories, hospitals, and others.
Various factors are adding to the global carrier screening market growth. As per the latest MRFR report, these factors comprise growing awareness about carrier screening, technological advances, growing emphasis on early detection prevention, increasing number of players involved new carrier screening technology development, and new product launch.
On the contrary, lack of standard guidelines, accuracy issues, the impact of COVID-19, and scarcity of skilled professionals are factors that may limit the global carrier screening products market growth over the forecast period.
Market Segmentation
The MRFR report gives an inclusive segmental analysis of the global carrier screening market report based on end users, technology, medical condition, type, and product service.
By product and service, the global carrier screening market growth is segmented into products services. Of these, the product segment will lead the market over the forecast period, followed by the services segment that is likely to grow at a fast pace.
By type, the global carrier screening market growth is segmented into targeted disease carrier screening and expanded carrier screening. Of these, the expanded carrier screening will dominate the market over the forecast period, followed by the targeted disease carrier screening segment that is likely to grow at a quick pace.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/8755
By medical conditions, the global carrier screening market growth is segmented into neurological conditions, haematological conditions, pulmonary conditions, and others.
By technology, the global carrier screening market growth is segmented into microarrays, polymerase chain reaction, and others.
By end user, the global carrier screening market growth is segmented into clinics, physician offices, reference laboratories, hospitals, and others.
Regional Analysis
Based on the region, the global carrier screening market growth report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), the Middle East and Africa. Of these, the Americas will have the lions share in the market over the forecast period. Increasing awareness about genetic disorders its diagnosis methods, and the huge patient population suffering from genetic diseases are adding to the global carrier screening market growth in the region.
The global carrier screening market in Europe is predicted to hold the second-largest share over the forecast period. The presence of several healthcare companies, rising focus on personalized medicine, and increasing RD activities are adding to the global carrier screening market growth in the region.
The global carrier screening market growth in the APAC region is predicted to grow at a fast pace over the forecast period. Increasing awareness regarding the diagnosis techniques of genetic disorder coupled with increasing market growth is adding to the global carrier screening market growth in the region.
The global carrier screening market in the MEA is predicted to have the smallest share over the forecast period for a low per capita disposable income, especially in Africa’s underdeveloped regions, lack of awareness regarding the disease condition, and limited healthcare infrastructure.
Key Players
Leading players profiled in the global carrier screening market report include Laboratory Corporation of America Holdings (US), Natera Inc (US), Luminex Corporation (US), Thermo Fisher Scientific Inc (US), Illumina Inc (US), Myriad Genetics (US), Sema4 (US), Quest Diagnostics Incorporated (US), Fulgent Genetics Inc (US), Opko Health (US), Invitae Corporation (US), and Eurofins Scientific (Luxembourg). Industry players have incorporated different strategies to create a niche in the market, such as acquisitions, mergers, new product launches, and more.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/sample_request/8755
Browse More Related Report:
Crohn’s Disease Market
https://www.marketresearchfuture.com/reports/crohns-disease-market-2344
Migraine Market
https://www.marketresearchfuture.com/reports/migraine-market-2381
Healthcare Biometrics Market
https://www.marketresearchfuture.com/reports/healthcare-biometrics-market-2450
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
